These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35316815)

  • 1. The Impact of COVID-19 and Vaccine on the Human Nervous System.
    Chen F; Cao P; Liu H; Cai D
    Neuroendocrinology; 2022; 112(11):1046-1057. PubMed ID: 35316815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.
    Geisen UM; Rose R; Neumann F; Ciripoi M; Vullriede L; Reid HM; Berner DK; Bertoglio F; Hoff P; Hust M; Longardt AC; Lorentz T; Martini GR; Saggau C; Schirmer JH; Schubert M; Sümbül M; Tran F; Voß M; Zeuner R; Morrison PJ; Bacher P; Fickenscher H; Gerdes S; Peipp M; Schreiber S; Krumbholz A; Hoyer BF
    J Med Virol; 2022 Dec; 94(12):5780-5789. PubMed ID: 35945627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of COVID-19 and mRNA vaccines on human fertility.
    Chen F; Zhu S; Dai Z; Hao L; Luan C; Guo Q; Meng C; Zhang Y
    Hum Reprod; 2021 Dec; 37(1):5-13. PubMed ID: 34734259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors.
    Lu BN; Zhu KL; Cui XM; Yao L; Wang XJ; Wang GL; Duan LJ; Qian A; Ma MJ
    Clin Immunol; 2022 Nov; 244():109103. PubMed ID: 36049602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
    Seaman MS; Siedner MJ; Boucau J; Lavine CL; Ghantous F; Liew MY; Mathews JI; Singh A; Marino C; Regan J; Uddin R; Choudhary MC; Flynn JP; Chen G; Stuckwisch AM; Lipiner T; Kittilson A; Melberg M; Gilbert RF; Reynolds Z; Iyer SL; Chamberlin GC; Vyas TD; Vyas JM; Goldberg MB; Luban J; Li JZ; Barczak AK; Lemieux JE
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36214224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social expectations and government incentives in Malaysia's COVID-19 vaccine uptake.
    Abdul Aziz NI; Flanders S; Nungsari M
    PLoS One; 2022; 17(9):e0275010. PubMed ID: 36156604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Uptake and Series Completion of COVID-19 Vaccine at Community-Based Vaccination for Latinos With Limited English Proficiency.
    Bigelow BF; Saxton RE; Martínez DA; Flores-Miller A; Shin JM; Parent C; Williams S; Phillips KH; Yang C; Page KR
    J Public Health Manag Pract; 2022 Nov-Dec 01; 28(6):E789-E794. PubMed ID: 36074797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant.
    Peled Y; Afek A; Kreiss Y; Rahav G; Nemet I; Kliker L; Indenbaum V; Ram E; Lavee J; Segev A; Matezki S; Sternik L; Raanani E; Lustig Y; Patel JK; Mandelboim M
    J Heart Lung Transplant; 2022 Oct; 41(10):1417-1425. PubMed ID: 35710484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine acceptance among medical students in Romania.
    Candrea E; Vargha JL; Todor N; Coman RT; Baican A; Filip A
    J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics Associated With a Previous COVID-19 Diagnosis, Vaccine Uptake, and Intention to Be Vaccinated Among Essential Workers in the US Household Pulse Survey.
    Steege AL; Luckhaupt SE; Guerin RJ; Okun AH; Hung MC; Syamlal G; Lu PJ; Santibanez TA; Groenewold MR; Billock R; Singleton JA; Sweeney MH
    Am J Public Health; 2022 Nov; 112(11):1599-1610. PubMed ID: 36223572
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expert recommendations on human papillomavirus vaccine immunization strategies in China].
    Zhang XX; Wang W; Song YF; Zhang ZN; Yu WZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Sep; 56(9):1165-1174. PubMed ID: 36207876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan.
    Yen CC; Wei KC; Wang WH; Huang YT; Chang YC
    JAMA Netw Open; 2022 Sep; 5(9):e2232571. PubMed ID: 36129709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS).
    Moro PL; Ennulat C; Brown H; Woody G; Zhang B; Marquez P; Woo EJ; Su JR
    Drug Saf; 2024 May; 47(5):487-493. PubMed ID: 38411838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in Europe, 30 July to 12 August 2022.
    Reyes-Urueña J; D'Ambrosio A; Croci R; Bluemel B; Cenciarelli O; Pharris A; Dukers-Muijrers N; Nutland W; Niaupari S; Badran J; Spiteri G; Noori T
    Euro Surveill; 2022 Oct; 27(42):. PubMed ID: 36268737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.
    Eslait-Olaciregui S; Llinás-Caballero K; Patiño-Manjarrés D; Urbina-Ariza T; Cediel-Becerra JF; Domínguez-Domínguez CA
    Ther Adv Drug Saf; 2023; 14():20420986231165674. PubMed ID: 37223456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.
    Thakur KT; Epstein S; Bilski A; Balbi A; Boehme AK; Brannagan TH; Wesley SF; Riley CS
    Neurology; 2021 Oct; 97(16):767-775. PubMed ID: 34475124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.